Capri Global Holdings sold 70,000 shares of Fredun Pharmaceuticals, trimming its stake from 1.45% to 1.01%.
A pharmaceutical manufacturer established in 1987, Fredun Pharma produces and exports a diverse range of healthcare and pharmaceutical products to domestic and international markets. The company specializes in the formulation and manufacturing of medicinal compounds serving hospitals, clinics, retail pharmacies, and healthcare institutions across multiple therapeutic categories. Its integrated operations span research, production, and distribution channels, positioning it as a versatile player in India's pharmaceutical sector.
Promoter holding company of listed NBFC Capri Global Capital, founded by Chartered Accountant Rajesh Sharma. Holds 41% of CGCL, which operates a diversified NBFC with consolidated AUM of Rs 22,860 crore across MSME, affordable housing, construction finance, car loans and gold loans, the latter having scaled to over Rs 16,960 crore across 1,000+ branches.
